Integrated Pharmacovigilance and Regulatory Safety Support
Available as part of HL Pharma’s Australian access, sponsorship, storage and supply services
Pharmacovigilance and regulatory safety support are important components of responsible product access, supply and sponsor oversight in Australia.
HL Pharma does not provide pharmacovigilance as a separate standalone outsourced service. Where clients engage HL Pharma across regulatory, local sponsorship, storage, distribution, Managed Access, Early Access or Post-Clinical Trial Supply activities, we can coordinate the safety activities connected to those arrangements.
This gives clients one Australian point of coordination across regulatory expectations, sponsor responsibilities, supply chain operations, adverse event escalation and TGA-aligned processes.
Integrated Pharmacovigilance Coordination in Australia
HL Pharma helps align local safety processes with the sponsor’s global pharmacovigilance framework, TGA expectations and the Australian service model in place.
Depending on the services in scope, this may include coordination of an Australian Pharmacovigilance Contact Person, adverse event and product complaint intake through agreed local channels, forwarding of safety cases into the sponsor’s global pharmacovigilance system, local literature checks, safety-related TGA communications and inspection-readiness support.
HL Pharma does not replace the sponsor’s pharmacovigilance responsibilities. Instead, we coordinate Australian safety activities connected to the products, patients and supply arrangements we support.
Specialist Safety Support within an Integrated Service Model
HL Pharma works with established pharmacovigilance specialists who bring drug and device safety expertise, including experience with regulatory expectations, safety systems and sponsor-facing processes.
This partner-led model helps keep safety-related activities connected to product access, supply continuity, quality documentation, adverse event escalation and TGA-facing communications, rather than managed separately from the broader sponsor and supply framework.
Quality, Compliance and Integration
Pharmacovigilance and regulatory safety support sits within HL Pharma’s broader quality, regulatory and logistics framework.
Our ISO 9001:2015-certified operations, electronic Quality Management System, GDP and GWP-aligned processes, and licensed temperature-controlled Melbourne facility help keep safety, quality, documentation and supply activities connected.
This model is suited to sponsors that need Australian pharmacovigilance coordination as part of a broader HL Pharma engagement, including local sponsorship, Managed Access, Early Access, Post-Clinical Trial Supply, storage, distribution or supply activities.
HL Pharma does not provide standalone pharmacovigilance outsourcing. Our role is to help coordinate safety-related activities within the wider Australian service model we support.